1–2 ml EDTA blood or 1–2 µg genomic DNA. Alternative material must be confirmed before collection or shipment.
FAMILY PLANNING
Fertility Panel
Phenotype-guided testing for inherited causes of fertility disorders.
Comprehensive panel sequencing with phenotype-guided interpretation.
Clinically relevant findings and reproductive implications.
Confirmed after case review.
CLINICAL VALUE
Where this test is strongest
✓Female and male fertility pathways
✓Phenotype-informed interpretation
✓Can inform family-planning discussion
✓Targeted alternative to broad exome testing
LIMITATIONS
What must remain visible
!Many fertility problems are not explained by a single genetic finding.
!Endocrine, reproductive, and clinical data remain essential.
GENE & ANALYTICAL SCOPE
Scope confirmed per case
The current phenotype-specific gene set is confirmed during case review.
Fertility gene panelCase-specific analytical scope+
Genes are selected from the current diagnostic portfolio according to the clinical question.
No fixed gene-by-gene list applies to this scope.
BEFORE ORDERING
Confirm the current laboratory specification.
The official case review and quotation confirm eligibility, accepted material, validated coverage and variant classes, consent, turnaround, price, and report pathway.